This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1986 Dec;19(5-6):313-4.

doi: 10.1007/BF01971235.

Disease modifying activity of HWA 486 on the development of SLE in MRL/1-mice

S Popovic, R R Bartlett

PMID: 3825747
DOI: 10.1007/BF01971235

Disease modifying activity of HWA 486 on the development of SLE in MRL/1-mice

S Popovic et al. Agents Actions. 1986 Dec.

. 1986 Dec;19(5-6):313-4.

doi: 10.1007/BF01971235.

Authors

S Popovic, R R Bartlett

PMID: 3825747
DOI: 10.1007/BF01971235

No abstract available

PubMed Disclaimer

Similar articles

Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection.
Bartlett RR, Dimitrijevic M, Mattar T, Zielinski T, Germann T, Rüde E, Thoenes GH, Küchle CC, Schorlemmer HU, Bremer E, et al. Bartlett RR, et al. Agents Actions. 1991 Jan;32(1-2):10-21. doi: 10.1007/BF01983301. Agents Actions. 1991. PMID: 2058454 Review.
Development of autoimmunity in MRL/lpr mice and the effects of drugs on this murine disease.
Bartlett RR, Popovic S, Raiss RX. Bartlett RR, et al. Scand J Rheumatol Suppl. 1988;75:290-9. doi: 10.3109/03009748809096781. Scand J Rheumatol Suppl. 1988. PMID: 3238364
Immunopharmacological profile of a novel isoxazol derivative, HWA 486, with potential antirheumatic activity--I. Disease modifying action on adjuvant arthritis of the rat.
Bartlett RR, Schleyerbach R. Bartlett RR, et al. Int J Immunopharmacol. 1985;7(1):7-18. doi: 10.1016/0192-0561(85)90003-7. Int J Immunopharmacol. 1985. PMID: 3873420
The use of the murine chronic graft vs host (CGVH) disease, a model for systemic lupus erythematosus (SLE), for drug discovery.
Popovic S, Bartlett RR. Popovic S, et al. Agents Actions. 1987 Aug;21(3-4):284-6. doi: 10.1007/BF01966492. Agents Actions. 1987. PMID: 3687582
Leflunomide: friend or foe for systemic lupus erythematosus?
Wu GC, Xu XD, Huang Q, Wu H. Wu GC, et al. Rheumatol Int. 2013 Feb;33(2):273-6. doi: 10.1007/s00296-012-2508-z. Epub 2012 Sep 8. Rheumatol Int. 2013. PMID: 22961090 Review.

See all similar articles

Cited by

Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection.
Bartlett RR, Dimitrijevic M, Mattar T, Zielinski T, Germann T, Rüde E, Thoenes GH, Küchle CC, Schorlemmer HU, Bremer E, et al. Bartlett RR, et al. Agents Actions. 1991 Jan;32(1-2):10-21. doi: 10.1007/BF01983301. Agents Actions. 1991. PMID: 2058454 Review.
DHODH and cancer: promising prospects to be explored.
Zhou Y, Tao L, Zhou X, Zuo Z, Gong J, Liu X, Zhou Y, Liu C, Sang N, Liu H, Zou J, Gou K, Yang X, Zhao Y. Zhou Y, et al. Cancer Metab. 2021 May 10;9(1):22. doi: 10.1186/s40170-021-00250-z. Cancer Metab. 2021. PMID: 33971967 Free PMC article. Review.
Effects of leflunomide on immune responses and models of inflammation.
Bartlett RR, Anagnostopulos H, Zielinski T, Mattar T, Schleyerbach R. Bartlett RR, et al. Springer Semin Immunopathol. 1993;14(4):381-94. doi: 10.1007/BF00192310. Springer Semin Immunopathol. 1993. PMID: 8322168 Review. No abstract available.
Effects of leflunomide on glomerulonephritis induced by antibasement membrane antibody in rats.
Ogawa T, Inazu M, Gotoh K, Hayashi S. Ogawa T, et al. Agents Actions. 1990 Nov;31(3-4):321-8. doi: 10.1007/BF01997627. Agents Actions. 1990. PMID: 2085146
4SC-101, a novel small molecule dihydroorotate dehydrogenase inhibitor, suppresses systemic lupus erythematosus in MRL-(Fas)lpr mice.
Kulkarni OP, Sayyed SG, Kantner C, Ryu M, Schnurr M, Sárdy M, Leban J, Jankowsky R, Ammendola A, Doblhofer R, Anders HJ. Kulkarni OP, et al. Am J Pathol. 2010 Jun;176(6):2840-7. doi: 10.2353/ajpath.2010.091227. Epub 2010 Apr 22. Am J Pathol. 2010. PMID: 20413687 Free PMC article.

See all "Cited by" articles

References

1. Int J Immunopharmacol. 1986;8(2):199-204 - PubMed
1. Int J Immunopharmacol. 1985;7(1):7-18 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information